What Is Seasonal Affective Disorder: Causes, Symptoms, and Light Therapy

This article is for informational purposes only. Consult a qualified healthcare professional for medical advice, diagnosis, or treatment.

What Is Seasonal Affective Disorder?

Seasonal affective disorder (SAD) is a recurrent form of major depressive disorder with a characteristic seasonal pattern—most commonly manifesting in autumn and winter and remitting in spring and summer. It was first formally described by Norman Rosenthal and colleagues at the National Institute of Mental Health (NIMH) in 1984. SAD affects approximately 4–6% of the US population in its full clinical form, with another 10–20% experiencing a milder subsyndromal version sometimes called "winter blues." It is more prevalent at higher latitudes, where reduced winter daylight hours are more pronounced; incidence rates in Florida are roughly 1.5%, compared to 9% in Alaska. Women are diagnosed 4 times more often than men.

Biological Mechanisms

Several interrelated biological mechanisms underlie SAD:

• Circadian rhythm disruption: Light is the primary synchronizer (zeitgeber) of the brain's internal clock, the suprachiasmatic nucleus (SCN). Reduced winter light input shifts the circadian phase, causing a misalignment between internal biological rhythms and the external light-dark cycle. This phase delay is associated with depression, hypersomnia, and cognitive slowing.
• Melatonin hypersecretion: The pineal gland secretes melatonin in the absence of light, signaling biological night. In winter, longer nights extend melatonin secretion duration. Some SAD research suggests extended melatonin secretion is a contributing factor, though melatonin supplementation has limited therapeutic evidence for SAD itself.
• Serotonin transporter (SERT) overexpression: A key finding in SAD neurobiology is increased SERT density in winter, which leads to more rapid serotonin reuptake from the synaptic cleft and effectively lower serotonin signaling—mirroring the pathophysiology of other depressive disorders. This finding helps explain why SSRIs are effective treatments for SAD.
• Dopamine and reward processing: Reduced dopaminergic activity contributes to the anhedonia, carbohydrate craving, and increased appetite/weight gain characteristic of SAD—a pattern notably different from the weight loss typical of non-seasonal melancholic depression.

Diagnostic Criteria (DSM-5)

SAD is classified in DSM-5 as Major Depressive Disorder with a Seasonal Pattern specifier. Diagnosis requires:

• A regular temporal relationship between the onset of major depressive episodes and a particular time of year (not just winter holiday stress)
• Full remissions (or a switch to hypomania/mania) occurring at a characteristic time of year
• Two or more seasonal major depressive episodes in the past 2 years with no non-seasonal episodes in the same period
• Seasonal episodes substantially outnumbering any lifetime non-seasonal episodes

Symptoms and Clinical Features

Light Therapy

Light therapy (phototherapy) is the first-line treatment for SAD, with over 30 years of controlled research supporting its efficacy. Treatment involves daily morning exposure to a bright light box emitting 10,000 lux of cool-white, fluorescent light (with UV filtered out) for 20–30 minutes within the first hour of waking. This dose mimics high-intensity natural outdoor light and suppresses extended melatonin secretion while correcting the circadian phase delay. Response rates are approximately 50–80%, with improvement typically observed within 1–2 weeks. Side effects are generally mild: headache, eye strain, nausea, and rare hypomania induction in bipolar disorder patients. Light therapy should be used with caution in individuals with bipolar disorder due to the risk of precipitating manic episodes.

Other Treatment Options

Summer SAD: The Less Common Pattern

A less common "summer SAD" variant (approximately 10% of SAD cases) presents with the opposite pattern: depression in spring/summer with remission in autumn/winter. Symptoms are also atypical for conventional SAD: insomnia, decreased appetite, weight loss, and agitation are more prominent. The mechanism is thought to involve sensitivity to heat and humidity or excessive light exposure rather than light deficiency. Treatment involves air-conditioned environments, cool water immersion, and sleep manipulation.

Prevention and Seasonal Management

For individuals with established SAD, preventive light therapy beginning in early autumn before symptom onset can delay or prevent the depressive episode. Starting bupropion XL in early autumn is an evidence-based pharmacological prevention strategy. Regular morning outdoor walks during winter—even on cloudy days, which still provide 1,000–10,000 lux outdoors versus indoor typical lighting of 100–500 lux—provide natural light input and benefit from the antidepressant effects of exercise.